Showing results (141-150 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|May 18, 2026
Rewiring the Leukemic Genome: 3D Chromatin Architecture in B-cell Acute Lymphoblastic LeukemiaTanja A GruberBlood Cancer Discovery|May 20, 2026
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcomaBettina Nadorp, Audrey Lasry, Sanam Loghavi, et al.Blood Cancer Discovery|July 15, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid LeukemiaJune Takeda, Kenichi Yoshida, Masahiro M Nakagawa, et al.Blood Cancer Discovery|July 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22Sumithira Vasu, Nathan Denlinger, No-Joon Song, et al.Blood Cancer Discovery|July 21, 2026
The Nicotinamide Salvage Pathway is a Metabolic Vulnerability of High-Risk MDS Stem CellsSweta B Patel, Daniel R Moskop, Steven Moreira, et al.Blood Cancer Discovery|August 14, 2026
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II AllelesEvey Y F Zheng, Chung-Hsi Wang, Toshiki Ochi, et al.Blood Cancer Discovery|September 2, 2026
Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRPQingyu Luo, Karley S Whalen, Xiaowei Wu, et al.Blood Cancer Discovery|August 31, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated DegradationLin Zhang, Arnold Bolomsky, Omar S Al-Odat, et al.Blood Cancer Discovery|July 16, 2021
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow MicroenvironmentGiada Bianchi, Peter G Czarnecki, Matthew Ho, et al.Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.Pageof 34